An Overview on the Evaluation and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

[1]  J. Goverman,et al.  Multidisciplinary care in Stevens-Johnson syndrome , 2020, Therapeutic advances in chronic disease.

[2]  Supriya Gupta,et al.  Stevens-Johnson Syndrome: A Perplexing Diagnosis , 2020, Cureus.

[3]  N. Dang,et al.  Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) , 2019, Oncologic Critical Care.

[4]  A. Schwartz,et al.  Incidence, outcomes, and resource use in children with Stevens‐Johnson syndrome and toxic epidermal necrolysis , 2018, Pediatric dermatology.

[5]  Y. Finkelstein,et al.  Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis , 2018, Drug Safety.

[6]  Philip R. Cohen,et al.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures , 2017, Advances in Therapy.

[7]  C. Watkins,et al.  Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  W. Chung,et al.  Severe cutaneous adverse drug reactions , 2016, The Journal of dermatology.

[9]  P. Dziewulski,et al.  UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. , 2016, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[10]  C. Chu,et al.  Long-term Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. , 2016, Acta dermato-venereologica.

[11]  Rachael Y Williams,et al.  Indications for intubation and early tracheostomy in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. , 2016, American journal of surgery.

[12]  N. Shear,et al.  Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update , 2015, American Journal of Clinical Dermatology.

[13]  R. Schwartz,et al.  Toxic epidermal necrolysis , 2020, Definitions.

[14]  G. Piérard,et al.  Deciphering supportive treatment strategies for toxic epidermal necrolysis. , 2012, Current drug safety.

[15]  L. Valeyrie-Allanore,et al.  [Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases]. , 2011, Annales de dermatologie et de venereologie.

[16]  F. Siemers,et al.  [Mechanical ventilation in toxic epidermal necrolysis]. , 2011, Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V....

[17]  L. French,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome , 2010, Orphanet journal of rare diseases.

[18]  G. Soubrane,et al.  Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2009, Archives of dermatology.

[19]  M. Mockenhaupt.  Severe drug‐induced skin reactions: clinical pattern, diagnostics and therapy , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[20]  M. Leyland,et al.  Early pathological features of the cornea in toxic epidermal necrolysis , 2007, British Journal of Ophthalmology.

[21]  J. M. Munro,et al.  Colonic involvement in Stevens-Johnson syndrome , 2006, Postgraduate Medical Journal.

[22]  C. Rubino,et al.  Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report. , 2005, British journal of plastic surgery.

[23]  J. Roujeau,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? , 2000, Archives of dermatology.

[24]  P. Kennedy,et al.  Clinical manifestations and outcomes in 17 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis , 1999, The Australasian journal of dermatology.